ArticleFrontiers in nutrition2025
Ketogenic diet as a therapeutic intervention for obsessive-compulsive disorder: a case series of three patients.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Hypomanic symptoms and first manic episode during ketogenic diet treatment in a patient taking venlafaxine: a case report with longitudinal glucose-ketone index and clinical monitoring.Frontiers in nutrition · 2026Article
- Participant food tracking in psychiatric ketogenic metabolic therapy: an unresolved clinical, psychosocial, and implementation question.Frontiers in nutrition · 2026Review
- Enhancing readiness for exposure and response prevention in obsessive compulsive disorder: ketogenic metabolic therapy as a candidate readiness adjunct.Frontiers in psychology · 2026Review
- Case Report: Metabolic, inflammatory, and neurological improvements after a ketogenic diet in a woman with treatment-resistant schizophrenia and metabolic syndrome.Frontiers in psychiatry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The ketogenic diet is being explored as a therapeutic intervention for the treatment of neuropsychiatric disorders. Emerging research suggests that these conditions share common pathophysiologies, with the ketogenic diet showing promise in addressing these. This study reports three individuals who reduced their symptoms of obsessive-compulsive disorder (OCD) after adopting a ketogenic diet. Methods: Participants were recruited through personal and professional networks among the authors. Each patient was interviewed, and evidence of their mental health history was collected. Their OCD symptoms were retrospectively assessed before and after adopting the diet using the Yale-Brown Obsessive Compulsive Scale (Y-BOCS). Results: The three participants in this case series have all achieved remission of their symptoms and are medication-free. The diet implementation reduced their average Y-BOCS scores by 21 points, corresponding to a mean decrease of 90.5%. In all cases, deviations from the ketogenic diet resulted in a return of their symptoms. Conclusion: The ketogenic diet may be an effective treatment for obsessive-compulsive disorder. Its capacity to improve the metabolic dysfunction associated with OCD may target the underlying mechanisms of the disorder. Controlled clinical trials of the ketogenic diet as a treatment for OCD are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.